Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1993-7-20
|
pubmed:abstractText |
L-leucyl-L-leucine methyl ester (Leu-Leu-OMe) is a lysosomotropic agent that selectively kills cytotoxic T cells and their precursors, natural killer cells, and monocytes but not helper T cells or other cells of hematopoietic origin. In this study, the effects of treatment of bone marrow and peripheral blood buffy coat with Leu-Leu-OMe on the outcome of allogeneic marrow transplantation were studied in several canine models. Whereas incubation of autologous marrow with Leu-Leu-OMe had no adverse effects on subsequent engraftment, incubation of marrow from dog leukocyte antigen (DLA)-identical littermates resulted in a high rate of graft failure. Previous studies have demonstrated that the addition of peripheral blood buffy coat allows engraftment of unrelated DLA-nonidentical marrow, and in this study we found that incubation of buffy coat with Leu-Leu-OMe did not alter this graft promoting effect. In a final experiment it was demonstrated that incubation of both marrow and peripheral blood buffy coat did not prevent the development of graft-versus-host disease in recipients of marrow from DLA-haploidentical littermates. In considering the eventual application of Leu-Leu-OMe in the clinic, these results are less encouraging than those previously reported using murine models.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0041-1337
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1244-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:8516809-Animals,
pubmed-meshheading:8516809-Antigen-Presenting Cells,
pubmed-meshheading:8516809-Bone Marrow Transplantation,
pubmed-meshheading:8516809-Cytotoxicity, Immunologic,
pubmed-meshheading:8516809-Dipeptides,
pubmed-meshheading:8516809-Dogs,
pubmed-meshheading:8516809-Graft Survival,
pubmed-meshheading:8516809-Graft vs Host Disease,
pubmed-meshheading:8516809-Histocompatibility Antigens,
pubmed-meshheading:8516809-Immunity, Innate,
pubmed-meshheading:8516809-Killer Cells, Natural,
pubmed-meshheading:8516809-Lymphocyte Depletion
|
pubmed:year |
1993
|
pubmed:articleTitle |
Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation.
|
pubmed:affiliation |
Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|